These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22982073)

  • 1. Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin.
    Liu W; Feng Q; Li Y; Ye L; Hu M; Liu Z
    Toxicol Appl Pharmacol; 2012 Dec; 265(3):316-24. PubMed ID: 22982073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition mechanisms of raloxifene in the human intestinal Caco-2 model.
    Jeong EJ; Lin H; Hu M
    J Pharmacol Exp Ther; 2004 Jul; 310(1):376-85. PubMed ID: 15020665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides.
    Qin Z; Li S; Yao Z; Hong X; Wu B; Krausz KW; Gonzalez FJ; Gao H; Yao X
    Food Funct; 2018 Mar; 9(3):1410-1423. PubMed ID: 29318243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
    Dahan A; Amidon GL
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
    Li Y; Song W; Ou X; Luo G; Xie Y; Sun R; Wang Y; Qi X; Hu M; Liu Z; Zhu L
    Drug Metab Dispos; 2019 Mar; 47(3):203-214. PubMed ID: 30602435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP.
    Jiang W; Xu B; Wu B; Yu R; Hu M
    Drug Metab Dispos; 2012 Feb; 40(2):336-45. PubMed ID: 22071170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic study on the intestinal absorption and disposition of baicalein.
    Zhang L; Lin G; Kovács B; Jani M; Krajcsi P; Zuo Z
    Eur J Pharm Sci; 2007 Jul; 31(3-4):221-31. PubMed ID: 17507208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable knock-down of efflux transporters leads to reduced glucuronidation in UGT1A1-overexpressing HeLa cells: the evidence for glucuronidation-transport interplay.
    Zhang X; Dong D; Wang H; Ma Z; Wang Y; Wu B
    Mol Pharm; 2015 Apr; 12(4):1268-78. PubMed ID: 25741749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmaceutical excipient PEG400 affect the absorption of baicalein in Caco-2 monolayer model by interacting with UDP-glucuronosyltransferases and efflux transport proteins.
    Cao S; Zhang M; Yuan M; Yang D; Zhao M; Zhang S; Wang P; Zhang R; Gao X
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00928. PubMed ID: 35148019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model.
    Hu M; Chen J; Lin H
    J Pharmacol Exp Ther; 2003 Oct; 307(1):314-21. PubMed ID: 12893842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efflux excretion of bisdemethoxycurcumin-O-glucuronide in UGT1A1-overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins 1 (MRP1) as the glucuronide transporters.
    Yang J; Zhang B; Qin Z; Li S; Xu J; Yao Z; Zhang X; Gonzalez FJ; Yao X
    Biofactors; 2018 Nov; 44(6):558-569. PubMed ID: 30334318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells.
    Prime-Chapman HM; Fearn RA; Cooper AE; Moore V; Hirst BH
    J Pharmacol Exp Ther; 2004 Nov; 311(2):476-84. PubMed ID: 15210835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco-2 cells through multidrug resistance-associated protein 2.
    Akao T; Hanada M; Sakashita Y; Sato K; Morita M; Imanaka T
    J Pharm Pharmacol; 2007 Jan; 59(1):87-93. PubMed ID: 17227625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters.
    Ming X; Knight BM; Thakker DR
    Mol Pharm; 2011 Oct; 8(5):1677-86. PubMed ID: 21780830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of chrysin glucuronidation in UGT1A1-overexpressing HeLa cells: elucidating the transporters responsible for efflux of glucuronide.
    Quan E; Wang H; Dong D; Zhang X; Wu B
    Drug Metab Dispos; 2015 Apr; 43(4):433-43. PubMed ID: 25595598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the efflux transport of demethoxycurcumin-O-glucuronides in HeLa cells stably transfected with UDP-glucuronosyltransferase 1A1.
    Zhang B; Yang J; Qin Z; Li S; Xu J; Yao Z; Zhang X; Gonzalez FJ; Yao X
    PLoS One; 2019; 14(5):e0217695. PubMed ID: 31150474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay of Efflux Transporters with Glucuronidation and Its Impact on Subcellular Aglycone and Glucuronide Disposition: A Case Study with Kaempferol.
    Li Y; Lu L; Wang L; Qu W; Liu W; Xie Y; Zheng H; Wang Y; Qi X; Hu M; Zhu L; Liu Z
    Mol Pharm; 2018 Dec; 15(12):5602-5614. PubMed ID: 30376625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glyceollin Effects on MRP2 and BCRP in Caco-2 Cells, and Implications for Metabolic and Transport Interactions.
    Chimezie C; Ewing A; Schexnayder C; Bratton M; Glotser E; Skripnikova E; Sá P; Boué S; Stratford RE
    J Pharm Sci; 2016 Feb; 105(2):972-981. PubMed ID: 26296158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific bidirectional efflux of 2,4-dinitrophenyl-S-glutathione, a substrate of multidrug resistance-associated proteins, in rat intestine and Caco-2 cells.
    Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
    J Pharm Pharmacol; 2007 Apr; 59(4):513-20. PubMed ID: 17430634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.
    Oswald S; Haenisch S; Fricke C; Sudhop T; Remmler C; Giessmann T; Jedlitschky G; Adam U; Dazert E; Warzok R; Wacke W; Cascorbi I; Kroemer HK; Weitschies W; von Bergmann K; Siegmund W
    Clin Pharmacol Ther; 2006 Mar; 79(3):206-17. PubMed ID: 16513445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.